01 July 1999
Med Sci Monit 1999; 5(4): PI754-757 :: ID: 504661
The aim of this study was to determine whether short term replacement therapy with estradiol and norethisterone affect the pharmacokinetics of phenazone. The study group comprised of 10 women, aged between 38-62 years, at least six weeks following ovariectomy. Each patient received estradiol (transdermally, 4 mg plaster every 3 days) for a period of 18 days, and subsequently norethisterone (orally, 5 mg per day) for 10 days, with an interval of one day. Pharmacokinetic studies were performed 3 times: prior to estradiol administration, on the last day of estradiol treatment and on the last day of norethisterone administration. Pharmacokinetic assays were performed following a single, oral administration of phenazone at a dose of 1.0 g, followed by blood sampling fora period of 24 hours, in order to determine plasma phenazone concentration levels. Brodi's method was applied for the measurement of phenazone concentrations. The one-compartment open model for extravascular administration was used for the calculations of pharmacokinetic parameters. Short-term administration of estradiol did not significantly alter pharmacokinetic parameter valuess determined during the study. Hormonal replacement therapy with norethisterone does not modify the pharmacokinetics of phenazone. Hormonal replacement therapy with both estradiol and norethisterone does not affect the biotransformation of phenazone.
Keywords: phenazone pharmacokinetics, norethisterone, Estradiol, hormonal replacement therapy
This Week Editorial
20 September 2021 : EditorialEditorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
Med Sci Monit 2021; 27:e934766
22 September 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic M...
Med Sci Monit In Press; DOI: 10.12659/MSM.934854
08 September 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit In Press; DOI: 10.12659/MSM.932788
16 July 2021 : Review articleSilent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.930776
24 Sep 2021 : Clinical ResearchA Single-Center Study of a Resin Inlay Dental Implant-Fixed Prosthesis for Closing Proximal Contact Loss in...
Med Sci Monit In Press; DOI: 10.12659/MSM.933809
24 Sep 2021 : Database AnalysisRelationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021)
Med Sci Monit In Press; DOI: 10.12659/MSM.933448
24 Sep 2021 : Database AnalysisA Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors
Med Sci Monit In Press; DOI: 10.12659/MSM.933559
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700